Loading…
Reported covered position: Detailee to the Energy and Commerce Committee, U.S. House of Representatives
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
TAYLOR FRESH FOODS, INC via SIDLEY AUSTIN LLP
2026 · second_quarter · 2T
Food regulation
Food regulation
Food regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
TAYLOR FRESH FOODS, INC via SIDLEY AUSTIN LLP
2026 · second_quarter · Q2
Food regulation
Food regulation
Food regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KARYOPHARM THERAPEUTICS via SIDLEY AUSTIN LLP
2026 · second_quarter · Q2
Rare disease policy, drug approval process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KARYOPHARM THERAPEUTICS via SIDLEY AUSTIN LLP
2026 · first_quarter · Q1
Rare disease policy, drug approval process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TAYLOR FRESH FOODS, INC via SIDLEY AUSTIN LLP
2026 · first_quarter · Q1
Food regulation
Food regulation
Food regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TAYLOR FRESH FOODS, INC via SIDLEY AUSTIN LLP
2025 · fourth_quarter · Q4
Food regulation
Food regulation
Food regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KARYOPHARM THERAPEUTICS via SIDLEY AUSTIN LLP
2025 · fourth_quarter · Q4
Rare disease policy, drug approval process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KARYOPHARM THERAPEUTICS via SIDLEY AUSTIN LLP
2025 · fourth_quarter · RA
Rare disease policy, drug approval process
KARYOPHARM THERAPEUTICS via SIDLEY AUSTIN LLP
2025 · fourth_quarter · RR
Rare disease policy, drug approval process
TAYLOR FRESH FOODS, INC via SIDLEY AUSTIN LLP
2025 · first_quarter · Q1
Food regulation
Food regulation
Food regulation
Food regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE